Actions of the phosphodiesterase inhibitor zardaverine on guinea-pig ventricular muscle
- PMID: 1700309
- DOI: 10.1007/BF00166968
Actions of the phosphodiesterase inhibitor zardaverine on guinea-pig ventricular muscle
Abstract
The positive inotropic action of the phosphodiesterase inhibitor zardaverine was investigated in guinea-pig heart muscle. In right papillary muscles, 1-30 microM zardaverine reversibly increased the force of contraction in a concentration-dependent manner. This effect was accompanied by a shortening of contraction and relaxation times. Resting membrane potential was unchanged, whereas action potential amplitude was significantly increased and duration was reduced. In papillary muscles partially depolarised with 22 mM K+, zardaverine (10 and 30 microM) restored slow action potentials, which were not influenced by cimetidine, propranolol or prazosin but were blocked by the calcium channel blocker (+)-nitrendipine or the muscarinic agonist carbachol. cAMP-specific phosphodiesterase III, isolated from guinea-pig ventricular muscle was inhibited by zardaverine as was cAMP-specific phosphodiesterase IV, isolated from dog trachea (IC50s: 0.5 and 0.8 microM, respectively). The results suggest that the observed positive inotropic and electrophysiological effects result from an inhibition of cellular phosphodiesterase.
Similar articles
-
Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.Arzneimittelforschung. 1999 May;49(5):398-406. doi: 10.1055/s-0031-1300434. Arzneimittelforschung. 1999. PMID: 10367101
-
Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.Arzneimittelforschung. 1994 May;44(5):583-8. Arzneimittelforschung. 1994. PMID: 7912931
-
Positive inotropic activity of 5-amino-6-cyano-1,3-dimethyl-1,2,3,4-tetrahydropyrido[2,3-d]pyrim idine-2,4-dione in cardiac muscle from guinea-pig and man. Part 6: Compounds with positive inotropic activity.Pharmazie. 1993 Jul;48(7):537-41. Pharmazie. 1993. PMID: 7692456
-
Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.Agents Actions Suppl. 1991;34:379-402. Agents Actions Suppl. 1991. PMID: 1665311 Review.
-
Phosphodiesterase inhibition and positive inotropic effects.J Cardiovasc Pharmacol. 1989;14 Suppl 3:S11-4. doi: 10.1097/00005344-198914003-00003. J Cardiovasc Pharmacol. 1989. PMID: 2478797 Review.
Cited by
-
Influence of selective phosphodiesterase inhibitors on human neutrophil functions and levels of cAMP and Cai.Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):682-90. doi: 10.1007/BF00174752. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1663589
-
Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors.Br J Pharmacol. 1991 Jun;103(2):1339-46. doi: 10.1111/j.1476-5381.1991.tb09790.x. Br J Pharmacol. 1991. PMID: 1653070 Free PMC article.
-
Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.Br J Pharmacol. 1993 Aug;109(4):1071-8. doi: 10.1111/j.1476-5381.1993.tb13731.x. Br J Pharmacol. 1993. PMID: 7691363 Free PMC article.
-
Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline.Br J Pharmacol. 1996 Apr;117(7):1413-20. doi: 10.1111/j.1476-5381.1996.tb15300.x. Br J Pharmacol. 1996. PMID: 8730733 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources